Healthy men swallow radioactive drug to track its path
NCT ID NCT07454863
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study gave 6 healthy men a single dose of a radioactive form of the experimental drug DZD8586. The goal was to see how the drug moves through the body, how it is broken down, and how it leaves the body in urine and stool. This information helps researchers understand the drug's behavior before testing it in people with lymphoma.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, NON-HODGKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, 214062, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single shot build a cancer army inside the body?
- Rare childhood bone lymphoma: can past cases guide future care?
- New pill targets Hard-to-Treat lymphoma in early human test
- Military study probes Toxins' role in lymphoma
- New transplant method aims to cut dangerous side effects in blood cancer patients
- Poop pills to prevent transplant rejection? new trial tests fecal transplants in blood cancer patients